The formation of new blood vessels (angiogenesis) is a crucial step in
the development of most solid tumors. Major advances in the identific
ation of molecular actors that are presumably involved in the angiogen
ic process have been obtained by studies on cultured endothelial cells
. However one may wonder if these actors that are active in vitro and
in various angiogenic assays are actually expressed in vivo during ang
iogenesis. Using specific nucleotidic probes and antibodies it became
recently possible to detect in vivo these presumptive molecular actors
including angiogenic factors, matrix degrading proteases and their in
hibitors, and transcription factors. The results of this contextual an
alysis, although fragmentary, challenge the models derived from in vit
ro analysis. These results will be essential for designing specific st
rategies aiming at the inhibition of tumor angiogenesis, which may res
ult in limiting the proliferation and spreading of tumor cells.